Skip to Content

C 745 (Glipizide Extended Release 5 mg)

Pill with imprint C 745 is Pink, Round and has been identified as Glipizide extended release 5 mg. It is supplied by Par Pharmaceutical, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 745

Glipizide extended release

Imprint:
C 745
Strength:
5 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical, Inc.
National Drug Code (NDC):
10370-0745

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide